1. A unifying approach for confidence intervals and testing of equivalence and difference
2. Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency. Guideline on the Choice of the Non‐Inferiority Margin. London UK July 27 2005. Available at:http://www.emea.europa.eu/pdfs/human/ewp/215899en.pdf.
3. Practical issues in equivalence trials
4. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases
5. Treatment evaluation in active control studies;Fleming T. R.;Cancer Treat Reports,1987